SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600
http://www.w3.org/2000/01/rdf-schema#comment
"farnesoid X receptor (FXR) genetic status and agonist treatment affects basal levels and phosphorylation state of Parp1 respectively; these alterations may be associated with hepatobiliary alterations observed in FXR-Knock out mice"
xsd:string
http://purl.uniprot.org/uniprot/#_491E6895A3B08E6CB368D9C84EC6C1BC3831F4AB3751FCBF1EA86EA226DECACB3EDA214D2FFF8D2DEBEFAD89E5DE8A6B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600
http://purl.uniprot.org/uniprot/Q3UX06
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600
http://purl.uniprot.org/uniprot/#_Q3UX06-mappedCitation-23178280
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4D940AB2CCAC573761250B877C1AFE6FAA525B621B1B8B349648FB61E0AED10DE33E6A906A5D926CD08975B8AF218600